The key to the success was that once recognized, cases dropped tremendously after treatment (refer to fig x). However, there was about 1% of the infected population that relapsed about a year (some cases two years) after the outbreak. Because the Mycoses Study Group Education and Research Consortium and CDC determination and consistency of conducting follow-up studies on these patients, these later cases of relapse were successfully identified; the latest case being November 2014 (Centers for Disease Control and Prevention, 2016). It has been stated that prolonged treatment of anti-fungal drugs may be a requirement for some patients with severe central nervous damage (Smith, Tipple, Chaudry, & Schaefer, 2013). According to the CDC as of October 2015, patient recovery from this outbreak should continue to be monitored and treated as clinicians see fit (Centers for Disease Control and Prevention,